Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Other Non Operating Income (2019 - 2025)

Historic Other Non Operating Income for Benitec Biopharma (BNTC) over the last 7 years, with Q1 2025 value amounting to $11000.0.

  • Benitec Biopharma's Other Non Operating Income rose 10932.2% to $11000.0 in Q1 2025 from the same period last year, while for Jun 2025 it was $868000.0, marking a year-over-year increase of 59318.18%. This contributed to the annual value of $764000.0 for FY2025, which is 47450.98% up from last year.
  • According to the latest figures from Q1 2025, Benitec Biopharma's Other Non Operating Income is $11000.0, which was up 10932.2% from $764000.0 recorded in Q4 2024.
  • Benitec Biopharma's 5-year Other Non Operating Income high stood at $764000.0 for Q4 2024, and its period low was -$507000.0 during Q3 2022.
  • Its 5-year average for Other Non Operating Income is -$13647.1, with a median of -$45000.0 in 2023.
  • As far as peak fluctuations go, Benitec Biopharma's Other Non Operating Income plummeted by 150000.0% in 2021, and later surged by 40263.16% in 2024.
  • Over the past 5 years, Benitec Biopharma's Other Non Operating Income (Quarter) stood at $48000.0 in 2021, then soared by 235.42% to $161000.0 in 2022, then dropped by 5.59% to $152000.0 in 2023, then skyrocketed by 402.63% to $764000.0 in 2024, then plummeted by 98.56% to $11000.0 in 2025.
  • Its Other Non Operating Income was $11000.0 in Q1 2025, compared to $764000.0 in Q4 2024 and $93000.0 in Q3 2024.